Accessibility and quality of drug company payment data disclosed via centralised industry databases and eurosfordocs.eu
Country | Name of regulation | Overseeing authority and database web link2–4 | Payment data accessibility* | Payment data quality* | |||||||
Document format | Single data template | Database searchable | Customisable summary statistics | Database downloadable | Characteristics included | Aggregation of payments | Payments with or without taxes | Unique identifiers | |||
Self-regulation at the European level—minimum requirements | |||||||||||
EFPIA | EFPIA Code | EFPIA | Not regulated | Yes (‘EFPIA disclosure template’), but deviations allowed | Not regulated | Not regulated | Not regulated | Donors; recipients; recipient location; payment categories and amounts; year | Annually per payment type | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | Optional |
Centralised online industry databases | |||||||||||
UK | ABPI Code of Practice | Association of the British Pharmaceutical Industry | Website, XLS | Yes | Yes | No | Yes | Donors; recipients; recipient categories (healthcare professionals) and location; payment categories and amounts; year; web links with further descriptions for some payments | Annually per payment type for healthcare professionals; payments to healthcare organisations itemised | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | No |
Czech Republic | Eticky Kodex AIPF | Asociace inovativního farmaceutického průmyslu | Website | Yes | Yes (but requires donor or recipient identifiers) | No | No | Donors; donor location; recipients; recipient location; payment categories and amounts; year | Annually per payment type | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | Recipient and donor identifiers |
Denmark | Ethical rules for the pharmaceutical industry’s donations and grants | Lægemiddelindustriforeningen | Readable PDFs | Yes | No | No | Yes | Donors; project name; recipients; product name; funded activity; payment goal; timescale of funded activity; payment amount and form (cash or benefit in kind) | No | Unclear | No |
Greece | SFEE Code of Conduct | Hellenic Association of Pharmaceutical Companies | Website | Yes | No | No | No | Donors; recipients; recipient categories; payment descriptions, categories goals, and amounts; date | No | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | No |
Ireland | Code of Practice of the Pharmaceutical Industry | Irish Pharmaceutical Healthcare Association | Website | Yes | No | No | No | Donors; recipients; recipient location; payment categories and amounts; year | Annually per payment type | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | Partial (recipient identifiers used by some companies) |
Industry data integrated within an independent database† | |||||||||||
Euros fordocs. eu | Codes of conduct in countries where data was collected‡ | N/A | Website, XLS | Yes | Yes | Yes | Yes | Donors; recipients; recipient location; payment categories and amounts; year | Annually per payment type for healthcare professionals (all countries). Annually per payment type for healthcare organisations in all countries but the UK, where payments to healthcare organisations are itemised | No single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosures | Spain: recipient identifiers. Other countries: No |
*Lighter colours indicate, respectively, higher, and darker colours—lower, data accessibility and quality. In the upper part of the table, the centralised industry databases are presented in the descending order of their overall data accessibility and quality, that is, the greater overall number of lighter cells a database has the higher its position within the table. Databases with equal numbers of lighter and darker cells are sorted alphabetically.
†The disclosure requirements ordinarily cover both healthcare professionals and organisations. The exceptions are the database run by the Danish pharmaceutical industry trade group (donations to hospitals) and the database run by the Greek pharmaceutical industry trade group (only payments to healthcare organisations).
‡Ireland, Italy, Germany, Spain, Sweden, Switzerland and the UK.
§Web links are accurate as of May 2021.
¶Some pharmaceutical industry trade groups create and delegate some responsibility for the everyday operation of their codes to sub-divisions such as the Ethical Committee for the Pharmaceutical Industry (established by Denmark’s LIF) or the Prescription Medicines Code of Practice Authority (established by the UK’s ABPI). However, the ultimate responsibility for managing and overseeing the codes is with the trade group.
EFPIA, European Federation of Pharmaceutical Industries and Associations; VAT, Value-added tax.